Upcoming Catalysts Fiscal year 2023/2024 just ended last Friday May, 31. During last quarter conference call, Irwin Simon predicted that Tilray would be cash flow positive this 1st quarter of 2024/2025. The 8 new brewery's were taking more work/time than anticipated to intergrate. We will see that very positive news mid October, 2024 during 1st Q conference call. With growing sales in German medical cannabis market, brews winning best of, opening in stadiums and expanding I think brews and medical cannabis, and distribution will be very good as well. 1st quarter we hit 1st year anniversary with most of the 8 new brewery's added last fall. Just Shock Top still has not been brought out and promoted as a national brew. Truss Infused Beverages started last fall also picking up sales in Canada. USA next or EU? Or both?
-
Sunday June 9 Slovenia voting to follow Germans lead and legalize Medical Cannabis. Small on its own but 1st EU country legalizing after Germany. I expect many to follow to get in on sales and taxes. EU is easy to drive across
-
Medmen bankruptcy should be completed this month. I suspect Tilray will take the beverages business, possibly grow facilities if they have prearranged an arms length company similar to Canopy & Sundial? Maybe retail in or near markets Tilray products are being sold into. A couple of months ago Irwin Simon stated they have plans for Medmen in Germany and I suspect EU as well. Hearing the 3 CEO/CFO of major German distributors on Zuanic podcast last week announce German Medical cannabis sales exceeding expectations in April (Cantourage 160% YOY sales increase) and that small pharmacies are popping up mainly just to get in on the profitable medical cannabis market, I think Medmen could be franchised to the independent pharmacists in Germany.
-
Tilray had arranged the extra shares thru shareholders voting during last AGM Nov 21, 2023 and just announced they may start selling up to about $250M of those. I suspect they will wait until Sch3 is approved and or Germany markets head up with the predicted 10X growth as stock price could be much higher.
-
What and when Tilray moves on other businesses is anyones guess. US Cannabis companies will certainly be cheaper pre rescheduling, but with licenses and facilities from Medmen they wouldn't need anymore US grow ops or retail. Could Tilray move on a German brewery business for Infused Drinks? I think that comes with Pillar 2? Will Pillar 2 be given the go ahead this quarter as a vote is not needed. Both possiblities before fall.
-
Tilray with businesses in numerous countries have many options to grow. Until the earnings, Tilray if they follow up to last year's growth, will be very busy
Copied from TLRY reddit